Cormorant Asset Management’s Puma Biotechnology PBYI Stock Holding History

Cormorant Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-167,300	Closed	-$39.5M	–	82
2015 Q1	$39.5M	Sell	167,300 -52,700	-24%	-$11.3M	6.1%	3
2014 Q4	$41.6M	Sell	220,000 -287,500	-57%	-$63.8M	6.46%	2
2014 Q3	$121M	Buy	507,500 +300,000	+145%	+$61.6M	24.95%	1
2014 Q2	$13.7M	Hold	207,500	–	–	3.67%	9
2014 Q1	$21.6M	Buy	207,500 +7,500	+4%	+$882K	4.97%	3
2013 Q4	$20.7M	Buy	+200,000	New	+$11.7M	6.01%	5

Other funds holding PBYI

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return